Clinical trial
Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia
NCT00162513 · Hadassah Medical Organization, Other · Withdrawn
Key facts
| NCT number | NCT00162513 |
|---|---|
| Title | Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia |
| Official title | Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Myeloid Leukemia |
| Intervention type | Biological |
| Interventions | Allogeneic tumor cell vaccine |
| Start date | Dec 1, 2006 |
| First posted | Sep 13, 2005 |
| Last update posted | Apr 28, 2011 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: